choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Circassia IPO

Circassia IPO Newsletter
  • Pulmonx Pursues $100 Million U.S. IPO 24 Sep 2020 23:54 GMT

    … (OTC:OCPNF) Broncus Medical Circassia Pharma AstraZeneca (AZN) GlaxoSmithKline … Listed underwriters of the IPO are BofA Securities, Morgan … that growth. Additionally, the IPO appears pricey given that … .S. IPOs with IPO Edge research. Members of IPO Edge get …

  • Pulmonx Files Initial U.S. IPO Registration Statement 07 Mar 2020 07:43 GMT

    … opinion when we learn more IPO details. Company & … System (OTC:OCPNF) Broncus Medical Circassia Pharma AstraZeneca (AZN) GlaxoSmithKline … . Listed bookrunners of the IPO are BofA Securities, Morgan … U.S. IPOs with IPO Edge research. Members of IPO Edge get …

  • Circassia, which has US headquarters in Morrisville, receives 2 boosts for lung products 12 Jul 2019 13:13 GMT

    … for its asthma products. Circassia, a specialty pharmaceutical company … . Purchasing Agreement Signed Circassia was awarded a group … important Premier contract brings Circassia one step closer to … 2014 it completed an initial public offering of stock on the …

  • FDA approves lung disease treatment from Circassia, which has HQ in Morrisville 18 Apr 2019 18:02 GMT

    … and regulatory submission. Circassia also has the commercial … ,” said David Acheson, Circassia’s senior vice president … knowing it. Circassia focused on respiratory disease Circassia is a … 2014 it completed an initial public offering of stock on the …

  • Circassia, with US HQ in Morrisville, to acquire rights to newborn respiratory device 25 Jan 2019 14:35 GMT

    … pharmaceutical business,” said Steve Harris, Circassia’s chief executive officer. “With … administration of inhaled nitric oxide. Circassia growing in respiratory disease market … . In 2014 it completed an initial public offering on the London Stock Exchange …

  • Circassia acquires rights to COPD drug, expanding staff 28 Dec 2018 20:35 GMT

    … million. Tudoza delivery system. Circassia photo. Circassia said it would satisfy the … . Recruited to Morrisville in 2012 Circassia, headquartered in Oxford, England, was … March 2014 it completed an initial public offering on the London Stock Exchange …

  • Circassia seeks shift to AIM after failing LSE criteria 12 Dec 2018 13:23 GMT

    … will be de-listed. Circassia’s £200m IPO on the LSE four … a time when US biotech IPOs are running at their highest … for many years. Since its IPO, Circassia has suffered a string of … said the takeover will give Circassia “significantly more control of the …

  • ‘Biotech is the ultimate impact investment’ — family offices can’t get enough of it 15 May 2023 04:32 GMT

    … , Oxford-based Circassia Pharmaceuticals, an allergy specialist, launched a £581mn initial public offering, a …

  • Oxford Nanopore surges 45per cent in rare London biotech listing 30 Sep 2021 12:19 GMT

    … enjoyed a strong run of IPOs this year yet biotech firms … since 2014 when allergy specialist Circassia went public and fetched a … opening 28per cent above their initial public offering (IPO) price of 425 pence. … worth of shares in the IPO. It had set its issue …

  • Oxford Nanopore surges 45% in rare London biotech listing 30 Sep 2021 08:37 GMT

    … enjoyed a strong run of IPOs this year yet biotech firms … since 2014 when allergy specialist Circassia went public and fetched a … after opening 28% above their initial public offering (IPO) price of 425 pence. … worth of shares in the IPO. It had set its issue …

Satisfied with the content?

Continue to create your account.